Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR-RCH-12002755Phase 4Completed
Phase 4, randomised trial of propofol and remifentanil (2 arms), sponsored by Women's Hospital, Zhejiang University School of Medicine. Primary endpoints: Effect-site concentration of propofol at different time points, Effect-site concentration of remifentanil at different time points and 3 more. Started Oct 2012; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR-RCH-12002755.